Publications
184
Citations
4,723
Est. group size
~13
Recurring co-author estimate
Active years
27
Publishing since 2000
Enver Özer researches surgical treatment of head and neck cancers, with a particular focus on transoral (through-the-mouth) and robotic surgery for HPV-related oropharyngeal (throat) cancer. Much of the recent work centers on a large national clinical trial (ECOG-ACRIN E3311) examining surgery combined with tailored radiation or chemotherapy afterward, as well as reconstructive techniques such as free flap surgery for facial and jaw defects. This research is clinically oriented, aiming to improve cancer control while preserving speech and swallowing function.
Publication output has fluctuated over the past decade, with a peak around 2020, a decline through 2022-2024, and a resurgence in 2025, suggesting variable but ongoing activity rather than steady linear growth.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Functional Impact of Transoral Surgery and Risk-Based Adjuvant Therapy in Human Papillomavirus–Associated Oropharyngeal Cancer: Swallowing Outcomes From ECOG-ACRIN E3311
JCO oncology advances. · 2025
- Long-Term Follow-Up of E3311, an ECOG-ACRIN Cancer Research Group Phase II Trial of Transoral Surgery and Risk-Based Adjuvant Treatment in Human Papillomavirus–Initiated Oropharynx Cancer
Journal of Clinical Oncology · 2025
- Long-term follow up of E3311, a phase II trial of transoral surgery (TOS) followed by pathology-based adjuvant treatment in HPV-associated (HPV+) oropharynx cancer (OPC): A trial of the ECOG-ACRIN Cancer Research Group.
Journal of Clinical Oncology · 2024
- Outcomes by time to adjuvant therapy in E3311, a phase II trial of transoral surgery (TOS) followed by pathology-based adjuvant treatment in HPV-associated (HPV+) oropharynx cancer (OPC): A trial of the ECOG-ACRIN Cancer Research Group.
Journal of Clinical Oncology · 2023
- Outcomes by tobacco history in E3311, a phase II trial of transoral surgery (TOS) followed by pathology-based adjuvant treatment in HPV-associated (HPV+) oropharynx cancer (OPC): A trial of the ECOG-ACRIN Cancer Research Group.
Journal of Clinical Oncology · 2022
- Future of Robotics in Otolaryngology–Head and Neck Surgery
2021
- Updated report of a phase II randomized trial of transoral surgical resection followed by low-dose or standard postoperative therapy in resectable p16+ locally advanced oropharynx cancer: A trial of the ECOG-ACRIN cancer research group (E3311).
Journal of Clinical Oncology · 2021
- Transoral robotic surgical resection followed by randomization to low- or standard-dose IMRT in resectable p16+ locally advanced oropharynx cancer: A trial of the ECOG-ACRIN Cancer Research Group (E3311).
Journal of Clinical Oncology · 2020
- Mega Fibula Free Flap for Reconstruction of an Extensive Mandibulofacial Defect
Annals of Otology Rhinology & Laryngology · 2020
- The Role of Hyperbaric Oxygen in Head and Neck Reconstruction and Facial Cosmetic Surgery
Facial Plastic Surgery · 2020
- A novel surgeon credentialing and quality assurance process using transoral surgery for oropharyngeal cancer in ECOG-ACRIN Cancer Research Group Trial E3311
Oral Oncology · 2020
- Transoral robotic excision of laryngocele: Surgical considerations
Head & Neck · 2019
- Laryngeal Robotic Surgery
2017
- Alterations in oral bacterial communities are associated with risk factors for oral and oropharyngeal cancer
Scientific Reports · 2017
- FIBROUS DYSPLASIA OF THE TEMPORAL BONE
2016
- Oral Oncology×14
- Head & Neck×13
- Journal of Clinical Oncology×8
- Otolaryngology×5
- JAMA Otolaryngology–Head & Neck Surgery×5
- Amit Agrawal
Medicine · The Ohio State University
- Stephen Y. Kang
Medicine · The Ohio State University
- Avinash V. Mantravadi
Medicine · Indiana University
- Theodoros N. Teknos
Medicine · The Ohio State University
- Lauren E. Miller
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile